AU2002247973A1 - Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases - Google Patents

Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases

Info

Publication number
AU2002247973A1
AU2002247973A1 AU2002247973A AU2002247973A AU2002247973A1 AU 2002247973 A1 AU2002247973 A1 AU 2002247973A1 AU 2002247973 A AU2002247973 A AU 2002247973A AU 2002247973 A AU2002247973 A AU 2002247973A AU 2002247973 A1 AU2002247973 A1 AU 2002247973A1
Authority
AU
Australia
Prior art keywords
epigallocatechin
gallate
prevention
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002247973A
Inventor
Hisanori Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consorzio per gli Studi Universitari di Verona
Original Assignee
Consorzio per gli Studi Universitari di Verona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consorzio per gli Studi Universitari di Verona filed Critical Consorzio per gli Studi Universitari di Verona
Publication of AU2002247973A1 publication Critical patent/AU2002247973A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002247973A 2001-03-12 2002-03-11 Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases Abandoned AU2002247973A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITVR2001A000031 2001-03-12
IT2001VR000031A ITVR20010031A1 (en) 2001-03-12 2001-03-12 USE OF EPIGALLOCATECHIN-3-GALLATO OR ITS DERIVATIVES IN THE PROPHYLAXIS AND TREATMENT OF NEURODEGENERATIVE DISEASES.
PCT/IT2002/000149 WO2002072086A2 (en) 2001-03-12 2002-03-11 Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
AU2002247973A1 true AU2002247973A1 (en) 2002-09-24

Family

ID=11461977

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002247973A Abandoned AU2002247973A1 (en) 2001-03-12 2002-03-11 Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases

Country Status (4)

Country Link
EP (1) EP1411920A2 (en)
AU (1) AU2002247973A1 (en)
IT (1) ITVR20010031A1 (en)
WO (1) WO2002072086A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041257A2 (en) * 2002-11-07 2004-05-21 Dsm Ip Assets B.V. Novel nutraceutical compositions comprising epigallocatechin gallate
TR200501978T2 (en) * 2002-11-28 2005-09-21 Dsm Ip Assets B.V. Nutraceutical compositions containing epigallocatesin gallate
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
ATE426575T1 (en) 2003-01-07 2009-04-15 Univ Ramot PEPTIDE ANOSTRUCTURES CONTAINING FOREIGN MATERIAL AND METHOD FOR PRODUCING THE SAME
WO2005027661A1 (en) * 2003-09-23 2005-03-31 Dsm Ip Assets B.V. Compositions for the treatment and prevention of diabetes mellitus
WO2005027901A1 (en) * 2003-09-25 2005-03-31 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2006013552A2 (en) 2004-08-02 2006-02-09 Ramot At Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
WO2006018850A2 (en) 2004-08-19 2006-02-23 Tel Aviv University Future Technology Development L.P. Compositions for treating amyloid associated diseases
US20100040558A1 (en) * 2005-04-26 2010-02-18 University Of South Florida Green tea polyphenol alpha secretase enhancers and methods of use
EP1973928A2 (en) 2005-10-11 2008-10-01 Ramot at Tel-Aviv University Ltd. Self-assembled fmoc-ff hydrogels
JP5576694B2 (en) * 2009-04-10 2014-08-20 花王株式会社 GIP elevation inhibitor
AU2014235962A1 (en) 2013-03-20 2015-09-10 Aptose Biosciences Inc. 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
WO2019236521A1 (en) * 2018-06-07 2019-12-12 Avanti Biosciences, Inc. Methods and formulations for intranasal administration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
DE19627344A1 (en) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutic composition containing epicatechin and/or theaflavin
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US5922756A (en) * 1998-02-14 1999-07-13 Chan; Marion Man-Ying Method of inhibiting nitric oxide synthase
ES2279627T3 (en) * 1998-07-31 2007-08-16 Sacks, Meir S. USE OF A COMBINATION THAT INCLUDES AN URIC AND ANTIOXIDANT PRECURSOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
FI20000004A0 (en) * 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke ...

Also Published As

Publication number Publication date
WO2002072086A3 (en) 2004-02-19
WO2002072086A8 (en) 2002-10-10
ITVR20010031A1 (en) 2002-09-12
WO2002072086A2 (en) 2002-09-19
EP1411920A2 (en) 2004-04-28
ITVR20010031A0 (en) 2001-03-12

Similar Documents

Publication Publication Date Title
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
HUP0400005A3 (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
EP1455780A4 (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
IL153439A0 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2002224253A1 (en) Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase